Fluniject 100ml

DESCRIPTION

Flunijekt (Flunijekt) - injection solution for the treatment of diseases of the musculoskeletal system and the removal of pain syndromes in animals. In appearance, the drug is a clear yellow liquid.

COMPOSITION

Fluniject in 1 ml contains flunixin meglumine - 83 mg (equivalent to 50 mg of flunixin) and excipients: sodium salicylate - 8 mg, sodium hydroxide - 40 mg, benzyl alcohol - 10 mg and water for injection up to 1 ml.

PURPOSE

Flunidject is prescribed to cattle, horses, pigs and dogs as an anti-inflammatory, analgesic and antipyretic agent in the complex therapy of respiratory, ophthalmological, obstetric-gynecological diseases, diseases of the musculoskeletal system and other pathologies accompanied by acute inflammatory pain syndromes, and and hyperthermia of various etiologies.

PHARMACOLOGICAL PROPERTIES

Fluniject belongs to the group of non-steroidal anti-inflammatory drugs. Flunixin meglumine, which is part of the drug, has a pronounced anti-inflammatory, analgesic and antipyretic effect. The main mechanism of its action is based on the ability to suppress the production of cyclooxygenases (COX1 and COX2), thereby inhibiting the synthesis of prostaglandins E2 - inflammatory mediators, under the influence of which the synthesis of inflammatory prostaglandins occurs, causing inflammation, edema and pain. After parenteral administration, flunixin meglumine is rapidly absorbed from the injection site and penetrates into most organs and tissues, reaching a maximum concentration in the blood after 10-45 minutes. Accumulating in the focus of inflammation, the drug provides a therapeutic effect lasting up to 24 hours. Flunixin is 99% bound to proteins

DOSAGE AND APPLICATION

Fluniject is administered parenterally to animals once a day:

For cattle - for respiratory, obstetric and gynecological diseases and other pathologies accompanied by acute inflammatory processes intravenously or intramuscularly at a dose of 2 ml per 45 kg of animal weight (2.2 mg / kg flunixin) until the clinical condition improves, but not more than 5 consecutive introductions.

Pigs - for respiratory, obstetric and gynecological diseases, MMA syndrome deep intramuscularly into the neck, once in a dose of 2 ml per 45 kg of animal weight (2.2 mg / kg of flunixin); if necessary again after 24 hours.

Dogs - to relieve inflammation and relieve pain in diseases of the musculoskeletal system, as an antipyretic agent intravenously or intramuscularly at a dose of 0.2 ml / 10 kg body weight (1 mg mg / kg flunixin) until the clinical condition improves, but not more than 3 consecutive introductions.

For horses, the drug is administered intravenously: - for diseases of the musculoskeletal system - 1 ml per 45 kg of weight (1.1 mg / kg of flunixin) once a day until the clinical condition improves, but no more than 5 consecutive injections; - for relief of pain in colic - 1 ml per 45 kg of body weight (1.1 mg / kg of flunixin) once, if necessary, again after 24 hours; - with endotoxemia, septic shock and other pathology associated with circulatory disorders in the gastrointestinal tract, as well as antipyretic remedies for infections of bacterial and viral etiology and after surgical interventions - 0.2 ml per 45 kg of body weight (0.22 mg / kg of flunixin) every 6-8 hours, until the clinical condition improves, but no more than 3 consecutive injections.

Due to the possible painful reaction, the drug should not be injected into one place in large animals in a volume exceeding 5 ml, in small animals in a volume exceeding 2.5 ml. In case of an overdose in an animal, symptoms of nephropathy, gastrointestinal bleeding, vomiting, acidosis, an increase in the content of transaminases in the blood are possible. In this case, the animal should be prescribed detoxification and symptomatic therapy. No peculiarities of the action were revealed during the first use of the drug and when it was canceled. In case of missing the next dose, the use of the drug is resumed in the same dose according to the same scheme.

SIDE EFFECTS

As a rule, there are no side effects and complications when using Flunijekt in accordance with this instruction. In pigs, a slight swelling may form at the injection site, which completely disappears within 14 days. With increased individual sensitivity and the appearance of allergic reactions, the use of the drug is discontinued and the animal is prescribed antihistamines and symptomatic therapy.

CONTRAINDICATIONS

Contraindication to use is the animal's hypersensitivity to the components of the drug, stomach and duodenal ulcer, hemorrhagic syndrome, acute renal, hepatic, heart failure, hypovolemia (except for endotoxemia or septic shock). The drug should not be used in pregnant females, young animals younger than 1.5 months of age, as well as piglets weighing less than 6 kg. Intra-aortic administration of Flunijekt, as well as its use in cats, is prohibited. Flunidject should not be used simultaneously with other anti-inflammatory drugs and drugs with nephrotoxic effects. With caution, under the constant supervision of a veterinarian, Flunidject is prescribed simultaneously with general anesthetics, anticoagulants and sulfonamides.

SPECIAL INSTRUCTIONS

Slaughter of animals for meat after the last application of Flunijekt is allowed: pigs no earlier than 28 days, horses no earlier than 8 days, cattle with intravenous administration no earlier than 8 days, with intramuscular administration no earlier than 35 days. Milk of dairy animals may be used for food purposes no earlier than 60 hours after the last use of the drug. Milk obtained earlier than the established period, after heat treatment, can be used in animal feed. Personal preventive measures. When working with Flunijekt, you should follow the general rules of personal hygiene and safety measures provided for when working with medicines. At the end of work, hands should be washed with warm water and soap. In case of accidental contact of the drug with the skin or mucous membranes of the eye, they should be washed immediately with plenty of water. People with hypersensitivity to the components of the drug should avoid direct contact with Fluniject. In case of allergic reactions or in case of accidental ingestion of the drug into the human body, you should immediately contact a medical institution (you should have instructions for use of the drug or a label with you). Empty vials from the drug must not be used for household purposes, they must be disposed of with household waste.

SHELF LIFE AND STORAGE

In the sealed manufacturer's packaging, in a dry place out of the reach of children. Separated from food and feed at temperatures from 5 C to 25 C. The shelf life of the drug, subject to storage conditions in a sealed package, is 3 years from the date of production, after opening the bottle - 28 days. It is prohibited to use Fluniject after the expiration date.

PACKAGING

Flunijekt is produced in 100 ml dark glass vials, sealed with rubber stoppers with aluminum caps.

Specifications

KolVUP

ten

Manufacturer

APICENNA

Temperature regime

from +5 to +25

Teaser

for the treatment of diseases of the musculoskeletal system and the removal of pain syndromes in animals